September is World Alzheimer’s Month
Date: 2021-09-01
World Alzheimer's Month is the international campaign every September to raise awareness for Alzheimer’s disease and how it impacts the daily lives of people affected by the condition and challenge the stigma that surrounds it. World Alzheimer's Day takes place on 21 September.
It is estimated that Alzheimer’s disease and related dementias afflicts on the order of 50 million patients worldwide today with a new case being registered every 3 seconds. Alzheimer’s disease accounts for approximately 60-80 percent of that number. In the absence of disease-modifying treatments that can stop or slow down the disease, dementia is currently growing by nearly 10 million cases every year, expected to reach more than 95 million before 2025 which highlights the high unmet medical need for innovative drugs in the area. The cost to society of dementia is currently estimated to be approximately USD 1 trillion annually.
Alzinova’s vision is “to enable patients to live an independent and active life without any impact of Alzheimer’s disease, by developing novel disease-modifying treatments.”
The lead candidate, ALZ-101, is a therapeutic vaccine for the treatment of Alzheimer’s and the first clinical study in patients is estimated to start during the third quarter. The antibody ALZ-201 is currently in early preclinical development phase.
“We are proud of our research and commitment to develop a therapy that has the potential to make a positive impact in the lives of the millions of people worldwide suffering from this terrible and devastating disease,” says Kristina Torfgård, CEO.